Biotech & Pharma

Tech Giant Apple has recently announced that the company will be expanding its capital return program. Its Board of Directors has authorized an increase of more than 50 percent to the Company’s program to return capital to shareholders. The Board had also increased its share repurchase authorization to $140 billion from the $90 billion level … Continue reading “Apple (Nasdaq: AAPL) Expands Capital Return Program”